De Burlo Group’s Globus Medical GMED Stock Holding History

De Burlo Group’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-35,800	Closed	-$1.81M	–	114
2018 Q2	$1.81M	Buy	+35,800	New	+$1.87M	0.38%	61

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

De Burlo Group's GMED Position: Q3 2018 in Review

De Burlo Group sold out of Globus Medical (GMED) in Q3 2018, closing a stake of 35,800 shares — an estimated $1.81M sold.

De Burlo Group first reported a position in GMED in Q2 2018 and held it in 1 quarter. The position peaked at $1.81M in Q2 2018. 312 funds tracked by Wall St. Rank hold GMED as of Q3 2018.

De Burlo Group reported no remaining Globus Medical position as of Q3 2018 after selling out during the quarter.
De Burlo Group sold 35,800 Globus Medical shares in Q3 2018, an estimated $1.81M.
De Burlo Group first reported a position in Globus Medical in Q2 2018 and held it in 1 quarter.
De Burlo Group's Globus Medical position peaked at $1.81M in Q2 2018.
312 funds tracked by Wall St. Rank held Globus Medical as of Q3 2018.

Based on De Burlo Group's 13F filing for Q3 2018, filed 8 Nov 2018.